cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sorrento Therapeutics Inc
117 own
105 watching
Current Price
$1.05
$0.01
(0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
491.71M
52-Week High
52-Week High
3.6
52-Week Low
52-Week Low
0.736
Average Volume
Average Volume
6.66M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
38.46
iconMarket Capitalization491.71M
icon52-Week High3.6
icon52-Week Low0.736
iconAverage Volume6.66M
iconDividend Yield--
iconP/E Ratio38.46
What does the Sorrento Therapeutics Inc do?
Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It develops therapeutic products for the treatment of auto-immune, inflammatory, neurodegenerative, and infectious diseases. The company offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain at end-stage disease. Its preclinical human therapeutic antibodies include antibody drug conjugates, bispecific approaches, and T-Cell Receptor, as well as Chimeric Antigen Receptor-T Cell (CAR-T) for adoptive cellular immunotherapy for the treatment of solid and liquid tumors. It is also involved in the development of T-007, an anti-CD38 CAR-T cellular therapy for the treatment of multiple myeloma, as well as for additional potential indications, such as amyloidosis and graft-versus-host disease; and T-009, an anti-CD123 CAR-T cellular therapy for the treatment of acute myelogenous leukemia. The company has license and collaboration agreement with Les Laboratoires Servier for the development, manufacture, and commercialization of products using its human immuno-oncology anti-PD-1 mAb STI-A1110. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California.
Read More
How much money does Sorrento Therapeutics Inc make?
News & Events about Sorrento Therapeutics Inc.
Globe Newswire
3days ago
PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain ...
Globe Newswire
4days ago
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (Nasdaq: SCLX, Scilex...
Insider Monkey
5days ago
In this article, we discuss the 5 hot healthcare stocks to buy now. If you want to read about some more hot healthcare stocks to buy now, go directly to 10 Hot Healthcare Stocks To Buy Now. 5. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Number of Hedge Fund Holders: 10 YTD Perf: 167.99% Avg Volume: ...
Globe Newswire
6days ago
PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a supplement to its previously issued Frequently Asked Questions document under the Investors section ...
Globe Newswire
9days ago
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a Frequently Asked Questions document under the Investors section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common ...
Frequently Asked Questions
Frequently Asked Questions
What is Sorrento Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Sorrento Therapeutics Inc shares?
plus_minus_icon
How can I buy Sorrento Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Sorrento Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sorrento Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Sorrento Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Sorrento Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sorrento Therapeutics Inc?
plus_minus_icon
What percentage is Sorrento Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sorrento Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.05
$0.01
(0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$13.15
$-0.02 (-0.15 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$11.75
$0.64 (5.76 %)
AxoGen, Inc.
AxoGen, Inc.
$9.28
$-0.04 (-0.43 %)
Regenxbio Inc
Regenxbio Inc
$24.02
$0.76 (3.27 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$13.15
$-0.02 (-0.15 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$11.75
$0.64 (5.76 %)
AxoGen, Inc.
AxoGen, Inc.
$9.28
$-0.04 (-0.43 %)
Regenxbio Inc
Regenxbio Inc
$24.02
$0.76 (3.27 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00